A Study of Bimatoprost 0.01% in the Clinical Setting
NCT01814761
·
clinicaltrials.gov ↗
COMPLETED
Status
312
Enrollment
INDUSTRY
Sponsor class
Conditions
Glaucoma, Primary Open Angle
Ocular Hypertension
Interventions
DRUG:
Bimatoprost 0.01%
Sponsor
Allergan